UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16
OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of March, 2019.
Commission File Number: 333-227131
FUQIN FINTECH LIMITED
(Translation of registrant’s name into English)
No.8 Guanghua Dongli
Zhonghai Guangchang, South Tower, 7th Floor
Chaoyang District, Beijing, PRC 100020
+86-010 8018 0588 – telephone
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Entry into a Material Definitive Agreement.
On March 29, 2019, Fuqin Fintech Limited, (the “Company”) entered into an Amendment No.1 to Underwriting Agreement (the “Amendment”) with Boustead Securities, LLC (the “Underwriter”) to extend the Underwriting Agreement dated December 10, 2018 in connection with Company’s proposed initial public offering (the “IPO”). Pursuant to the Amendment, the offering period of the IPO has been extended until May 30, 2019.
Concurrently, the Company and the Underwriter have promptly notified FinTech Clearing, LLC (the “Deposit Account Agent”) the extension of the IPO.
The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Amendment, which is filed as Exhibit 10.1 and is incorporated herein by reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Date: April 1, 2019 | FUQIN FINTECH LIMITED |
| | | |
| | By: | /s/ Xinglaing Li |
| | Name: | Xingliang Li |
| | Title: | Chief Executive Officer and Director |
2
